Header Logo

Connection

Caroline Tiemessen to Male

Back to Details
This is a "connection" page, showing publications Caroline Tiemessen has written about Male.
Caroline Tiemessen
Connection Strength
2,048
Male
  1. Human models that inform antiretroviral therapy-free remission with perinatally acquired HIV infection. Curr Opin HIV AIDS. 2025 May 01; 20(3):249-256.
    View in: PubMed
    Score: 0,105
  2. Higher CCR5 density on CD4 + T-cells in mothers and infants is associated with increased risk of in-utero HIV-1 transmission. AIDS. 2024 06 01; 38(7):945-954.
    View in: PubMed
    Score: 0,098
  3. Reduced CCR5 Expression and Immune Quiescence in Black South African HIV-1 Controllers. Front Immunol. 2021; 12:781263.
    View in: PubMed
    Score: 0,084
  4. Fc?R Genetic Variation and HIV-1 Vaccine Efficacy: Context And Considerations. Front Immunol. 2021; 12:788203.
    View in: PubMed
    Score: 0,084
  5. An HIV Vaccine Protective Allele in FCGR2C Associates With Increased Odds of Perinatal HIV Acquisition. Front Immunol. 2021; 12:760571.
    View in: PubMed
    Score: 0,084
  6. Systemic DPP4/CD26 is associated with natural HIV-1 control: Implications for COVID-19 susceptibility. Clin Immunol. 2021 09; 230:108824.
    View in: PubMed
    Score: 0,082
  7. Interleukin-8 genetic diversity, haplotype structure and production differ in two ethnically distinct South African populations. Cytokine. 2021 07; 143:155489.
    View in: PubMed
    Score: 0,080
  8. The impact of bone marrow stromal antigen-2 (BST2) gene variants on HIV-1 control in black South African individuals. Infect Genet Evol. 2020 06; 80:104216.
    View in: PubMed
    Score: 0,074
  9. Human leukocyte antigen class I (A, B, C) and class II (DPB1, DQB1, DRB1) allele and haplotype variation in Black South African individuals. Hum Immunol. 2020 Jan; 81(1):6-7.
    View in: PubMed
    Score: 0,073
  10. Detection and molecular characterization of urinary tract HIV-1 populations. Ann Clin Microbiol Antimicrob. 2019 Sep 24; 18(1):27.
    View in: PubMed
    Score: 0,072
  11. Cis-regulatory genetic variants in the CCR5 gene and natural HIV-1 control in black South Africans. Clin Immunol. 2019 08; 205:16-24.
    View in: PubMed
    Score: 0,070
  12. Chronic HIV-1 Infection Alters the Cellular Distribution of Fc?RIIIa and the Functional Consequence of the Fc?RIIIa-F158V Variant. Front Immunol. 2019; 10:735.
    View in: PubMed
    Score: 0,070
  13. The FCGR2C allele that modulated the risk of HIV-1 infection in the Thai RV144 vaccine trial is implicated in HIV-1 disease progression. Genes Immun. 2019 11; 20(8):651-659.
    View in: PubMed
    Score: 0,068
  14. Age at antiretroviral therapy initiation and cell-associated HIV-1 DNA levels in HIV-1-infected children. PLoS One. 2018; 13(4):e0195514.
    View in: PubMed
    Score: 0,065
  15. CXCR6 gene characterization in two ethnically distinct South African populations and association with viraemic disease control in HIV-1-infected black South African individuals. Clin Immunol. 2017 07; 180:69-79.
    View in: PubMed
    Score: 0,061
  16. RICH2 is implicated in viraemic control of HIV-1 in black South African individuals. Infect Genet Evol. 2017 04; 49:78-87.
    View in: PubMed
    Score: 0,060
  17. Young age at start of antiretroviral therapy and negative HIV antibody results in HIV-infected children when suppressed. AIDS. 2015 Jun 01; 29(9):1053-60.
    View in: PubMed
    Score: 0,053
  18. Frequencies of immune hypersensitivity reaction-associated HLA class I alleles in healthy South African Indian and mixed ancestry populations determined by a novel real-time PCR assay. Tissue Antigens. 2014 Oct; 84(4):389-97.
    View in: PubMed
    Score: 0,051
  19. Comparison of a quantitative Real-Time PCR assay and droplet digital PCR for copy number analysis of the CCL4L genes. Infect Genet Evol. 2014 Jul; 25:28-35.
    View in: PubMed
    Score: 0,049
  20. KIR2DS4 allelic variants: Differential effects on in utero and intrapartum HIV-1 mother-to-child transmission. Clin Immunol. 2013 Dec; 149(3):498-508.
    View in: PubMed
    Score: 0,048
  21. Differences are evident within the CXCR4-CXCL12 axis between ethnically divergent South African populations. Cytokine. 2013 Mar; 61(3):792-800.
    View in: PubMed
    Score: 0,046
  22. A novel FCGR3A intragenic haplotype is associated with increased Fc?RIIIa/CD16a cell surface density and population differences. Hum Immunol. 2013 May; 74(5):627-34.
    View in: PubMed
    Score: 0,046
  23. Marked differences in CCR5 expression and activation levels in two South African populations. Immunology. 2012 Aug; 136(4):397-407.
    View in: PubMed
    Score: 0,044
  24. Identification of human immunodeficiency virus-1 specific CD8+ and CD4+ T cell responses in perinatally-infected infants and their mothers. AIDS. 2009 Apr 27; 23(7):789-98.
    View in: PubMed
    Score: 0,035
  25. African infants' CCL3 gene copies influence perinatal HIV transmission in the absence of maternal nevirapine. AIDS. 2007 Aug 20; 21(13):1753-61.
    View in: PubMed
    Score: 0,031
  26. HIV-1 Elite Controllers Are Characterized by Elevated Levels of CD69-Expressing Natural Killer Cells. J Acquir Immune Defic Syndr. 2024 Dec 15; 97(5):522-532.
    View in: PubMed
    Score: 0,026
  27. Growth Trajectories Over the First Year of Life Among Early-Treated Infants with Human Immunodeficiency Virus and Infants Who are Human Immunodeficiency Virus-Exposed Uninfected. J Pediatr. 2024 Jul; 270:114018.
    View in: PubMed
    Score: 0,025
  28. Characterization of HIV-1 Reservoirs in Children and Adolescents: A?Systematic Review and Meta-Analysis Toward Pediatric HIV Cure. J Pediatr. 2024 Apr; 267:113919.
    View in: PubMed
    Score: 0,024
  29. Inflammatory profile of vertically HIV-1 infected adolescents receiving ART in Cameroon: a contribution toward optimal pediatric HIV control strategies. Front Immunol. 2023; 14:1239877.
    View in: PubMed
    Score: 0,024
  30. Microbiota in the oral cavity of school-age children with HIV who started antiretroviral therapy at young ages in South Africa. AIDS. 2023 08 01; 37(10):1583-1591.
    View in: PubMed
    Score: 0,023
  31. Coronavirus Host Genomics Study: South Africa (COVIGen-SA). Glob Health Epidemiol Genom. 2022; 2022:7405349.
    View in: PubMed
    Score: 0,022
  32. Deep sequencing of the HIV-1 polymerase gene for characterisation of cytotoxic T-lymphocyte epitopes during early and chronic disease stages. Virol J. 2022 03 28; 19(1):56.
    View in: PubMed
    Score: 0,021
  33. Human immunodeficiency virus type 1 envelope-stimulated interleukin-2 production and survival of infected children with severe and mild clinical disease. J Infect Dis. 2001 Sep 15; 184(6):691-8.
    View in: PubMed
    Score: 0,021
  34. Reduced HIV-stimulated T-helper cell reactivity in cord blood with short-course antiretroviral treatment for prevention of maternal-infant transmission. Clin Exp Immunol. 2001 Mar; 123(3):443-50.
    View in: PubMed
    Score: 0,020
  35. Human leukocyte antigen associations with protection against tuberculosis infection and disease in human immunodeficiency virus-1 infected individuals, despite household tuberculosis exposure and immune suppression. Tuberculosis (Edinb). 2021 01; 126:102023.
    View in: PubMed
    Score: 0,020
  36. Quantifying the Dynamics of HIV Decline in Perinatally Infected Neonates on Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2020 10 01; 85(2):209-218.
    View in: PubMed
    Score: 0,019
  37. HIV diagnostic challenges in breast-fed infants of mothers on antiretroviral therapy. AIDS. 2019 09 01; 33(11):1751-1756.
    View in: PubMed
    Score: 0,018
  38. Partner HIV Serostatus Impacts Viral Load, Genital HIV Shedding, and Immune Activation in HIV-Infected Individuals. J Acquir Immune Defic Syndr. 2019 09 01; 82(1):51-60.
    View in: PubMed
    Score: 0,018
  39. Impaired interleukin-8-induced degranulation of polymorphonuclear neutrophils from human immunodeficiency virus type 1-infected individuals. Clin Diagn Lab Immunol. 1999 May; 6(3):345-51.
    View in: PubMed
    Score: 0,018
  40. Dysregulated production of interleukin-8 in individuals infected with human immunodeficiency virus type 1 and Mycobacterium tuberculosis. Infect Immun. 1999 Mar; 67(3):1251-60.
    View in: PubMed
    Score: 0,017
  41. Reduced expression of interleukin-8 receptors A and B on polymorphonuclear neutrophils from persons with human immunodeficiency virus type 1 disease and pulmonary tuberculosis. J Infect Dis. 1998 Apr; 177(4):921-30.
    View in: PubMed
    Score: 0,016
  42. Prevalence and outcomes of HIV-1 diagnostic challenges during universal birth testing - an urban South African observational cohort. J Int AIDS Soc. 2017 08 29; 20(Suppl 6):21761.
    View in: PubMed
    Score: 0,016
  43. CCR5 expression, haplotype and immune activation in protection from infection in HIV-exposed uninfected individuals in HIV-serodiscordant relationships. Immunology. 2017 08; 151(4):464-473.
    View in: PubMed
    Score: 0,015
  44. Pre-treatment minority HIV-1 drug resistance mutations and long term virological outcomes: is prediction possible? Virol J. 2016 10 12; 13(1):170.
    View in: PubMed
    Score: 0,015
  45. Serum levels of inflammatory cytokines in Rift Valley fever patients are indicative of severe disease. Virol J. 2015 Oct 06; 12:159.
    View in: PubMed
    Score: 0,014
  46. Viral genetic determinants of nonprogressive HIV type 1 subtype C infection in antiretroviral drug-naive children. AIDS Res Hum Retroviruses. 2009 Nov; 25(11):1141-8.
    View in: PubMed
    Score: 0,009
  47. Genetic variants of NRAMP1 and active tuberculosis in Japanese populations. International Tuberculosis Genetics Team. Clin Genet. 2000 Jul; 58(1):74-6.
    View in: PubMed
    Score: 0,005
  48. Identification of HIV type 1 intersubtype recombinants in South Africa using env and gag heteroduplex mobility assays. AIDS Res Hum Retroviruses. 2000 Mar 20; 16(5):493-7.
    View in: PubMed
    Score: 0,005
  49. Value of cerebrospinal fluid leukocyte aggregation in distinguishing the causes of meningitis in children. Pediatr Infect Dis J. 2000 Jan; 19(1):66-72.
    View in: PubMed
    Score: 0,005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.